Prescription Drug Costs in Focus: PBM Reform on the Horizon

Complications: Health Policy Unraveled

Pharmacy benefit managers (PBMs) continue to be a topic which causes angst in Congress. However, PBM reform is not far off, and is likely to come before the end of the year.

In episode 11 of Complications: Health Policy Unraveled, host Stephanie Kennan discusses the bipartisan introduction of the Patients Before Middlemen Act in the Senate, which is aimed at realigning incentives that help lower prescription drug costs for Medicare Part D beneficiaries. Additionally, this episode highlights the broader legislative efforts to address drug pricing issues. Tune in to this episode to learn more.

Meet Your Host

Name: Stephanie Kennan

Title: Senior Vice President, Federal Public Affairs at McGuireWoods Consulting

Specialty: Stephanie Kennan helps clients navigate the legislative and executive branches of the federal government to solve problems involving a variety of healthcare policy issues. Her work focuses on providers, medical device manufacturers, drug manufacturers and associations concerned about Medicare and Medicaid reimbursement.

Connect: LinkedIn

Episode Highlights

[00:45] Senate introduces the Patients Before Middlemen Act

[01:37] The impact of the Patients Before Middlemen Act on PBM compensation

[02:05] Other legislative efforts to address prescription drug pricing issues

[03:55] PBM reform is not far off

Contact

Connect with us on Facebook, Twitter, LinkedIn, YouTube.

Subscribe to Complications: Health Policy Unraveled in your preferred podcast app and never miss a healthcare update by subscribing to host and JD Supra’s #1 healthcare author Stephanie Kennan’s Washington Healthcare Update at www.mwcllc.com